Lifeloc Technologies Inc 's Cash & cash equivalent grew by 59.52 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Lifeloc Technologies Inc 's Quick Ratio to 0.83, Quick Ratio remained below Lifeloc Technologies Inc average.

Within Laboratory Analytical Instruments industry 13 other companies have achieved higher Quick Ratio than Lifeloc Technologies Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2501 to 2560.

Explain Quick Ratio?
How much Cash & cash equivalents LCTC�s has?
What are LCTC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LCTC Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	28.5 %	6.7 %	3.96 %	22.95 %	-1.27 %
Y / Y Cash & cash equivalent Change	-8.8 %	-62.61 %	-40.02 %	-18.6 %	97.34 %
Quick Ratio MRQ	0.83	0.56	0.96	0.79	1.16
LCTC's Total Ranking	# 2560	# 2501	# 2539	# 2166	# 1859
Seq. Current Liabilities Change	7.87 %	30.99 %	-10.68 %	1.82 %	-10.43 %
Seq. Cash & cash equivalent Change	59.52 %	-23.68 %	8.89 %	-31.2 %	-34.59 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 14
Healthcare Sector	# 664
Overall Market	# 2144

Quick Ratio Statistics
High	Average	Low
5.24	2.93	0.56
(Dec 31 2016)		(Mar 31 2026)

Financial Statements
Lifeloc Technologies Inc 's Current Liabilities	$ 1 Millions	Visit LCTC's Balance sheet
Lifeloc Technologies Inc 's Cash & cash equivalent	$ 1 Millions	Visit LCTC's Balance sheet
Source of LCTC's Sales		Visit LCTC's Sales by Geography

Cumulative Lifeloc Technologies Inc 's Quick Ratio

LCTC's Quick Ratio for the trailling 12 Months

LCTC Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	15.3 %	7.48 %	7.1 %	-0.17 %	-11.37 %
Y / Y Cash & cash equivalent TTM Growth	-36.82 %	-27.14 %	9.06 %	7.3 %	-15.37 %
Quick Ratio TTM	0.77	0.85	1.14	1.3	1.41
Total Ranking TTM	# 1521	# 1448	# 980	# 943	# 1066
Seq. Current Liabilities TTM Growth	6.92 %	1.85 %	0.86 %	4.98 %	-0.34 %
Seq. Cash & cash equivalent TTM Growth	-2.92 %	-24.13 %	-11.19 %	-3.4 %	11.94 %

Quick ratio ranking by company, industry and sector >> Back to LCTC Financial Strength Comparisons >> Go to Compare LCTC Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $1.10 millions, cumulative Quick Ratio decreased to 0.77 below the Lifeloc Technologies Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Lifeloc Technologies Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2958.

Explain Quick Ratio?
How much Cash & cash equivalents LCTC�s has?
What are LCTC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 900
Within the Market	# 2560

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.56	2.86	0.74
(Dec 31 2016)		(Jun 30 2026)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Quanterix Corporation	1.86	$ 93.529 Millions	$ 50.373 Millions
Nautilus Biotechnology Inc	1.52	$ 13.166 Millions	$ 8.639 Millions
Rapid Micro Biosystems Inc	1.13	$ 20.500 Millions	$ 18.150 Millions
Bionano Genomics Inc	1.04	$ 10.420 Millions	$ 10.039 Millions
Bio rad Laboratories Inc	0.92	$ 886.900 Millions	$ 961.300 Millions
Precipio inc	0.83	$ 3.075 Millions	$ 3.701 Millions
Lifeloc Technologies Inc	0.83	$ 0.908 Millions	$ 1.099 Millions
Agilent Technologies inc	0.77	$ 1,758.000 Millions	$ 2,289.000 Millions
Revvity Inc	0.67	$ 1,022.943 Millions	$ 1,516.157 Millions
Harvard Bioscience Inc	0.26	$ 6.503 Millions	$ 24.793 Millions
Waters Corporation	0.22	$ 539.000 Millions	$ 2,399.000 Millions
Kewaunee Scientific Corporation	0.22	$ 10.261 Millions	$ 47.235 Millions
Bruker Corporation	0.18	$ 217.200 Millions	$ 1,204.700 Millions

Date modified: 2026-09-26T07:15:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.